Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

The Tennessee high school swimming season concluded with the TISCA championships this weekend. Here are five takeaways from ...

Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.